Cargando…

Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy

Cancer cells typically exhibit a tightly regulated program of metabolic plasticity and epigenetic remodeling to meet the demand of uncontrolled cell proliferation. The metabolic–epigenetic axis has recently become an increasingly hot topic in carcinogenesis and offers new avenues for innovative and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao-Yu, Pi, Ya-Nan, Chen, Yao, Zhu, Qi, Xia, Bai-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218565/ https://www.ncbi.nlm.nih.gov/pubmed/35756670 http://dx.doi.org/10.3389/fonc.2022.894744

Ejemplares similares

Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms
por: Pozzi, Valentina, et al.
Publicado: (2022)

Nicotinamide N-methyltransferase and liver diseases
por: Liang, Guangyu, et al.
Publicado: (2022)

Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Wu, Miaowei, et al.
Publicado: (2020)

Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers
por: Campagna, Roberto, et al.
Publicado: (2021)

Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes
por: Liu, Jie-Ru, et al.
Publicado: (2021)

Nicotinamide N-Methyltransferase in Health and Cancer
por: Ramsden, David B, et al.
Publicado: (2017)

Nicotinamide N-Methyltransferase: Genomic Connection to Disease
por: Ramsden, David B, et al.
Publicado: (2020)

Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
por: Reustle, Anna, et al.
Publicado: (2022)

Physiological Study on Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Hyperlipidemia
por: Zhu, Xiao-Juan, et al.
Publicado: (2016)

Complex roles of nicotinamide N-methyltransferase in cancer progression
por: Wang, Weixuan, et al.
Publicado: (2022)

Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer
por: Novak Kujundžić, Renata, et al.
Publicado: (2021)

Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity
por: Gao, Yongzhi, et al.
Publicado: (2019)

Novel Inhibitors of Nicotinamide-N-Methyltransferase for the Treatment of Metabolic Disorders
por: Kannt, Aimo, et al.
Publicado: (2021)

Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT)
por: van Haren, Matthijs J., et al.
Publicado: (2021)

DNA Methyltransferases: A Novel Target for Prevention and Therapy
por: Subramaniam, Dharmalingam, et al.
Publicado: (2014)

The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update
por: Campagna, Roberto, et al.
Publicado: (2021)

Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
por: Kim, Jongmin, et al.
Publicado: (2009)

Nicotinamide-N-Methyltransferase gene rs694539 variant and migraine risk
por: Sazci, Ali, et al.
Publicado: (2016)

Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation
por: Roberti, Annalisa, et al.
Publicado: (2021)

High Expression of Nicotinamide N-Methyltransferase in Patients with Sporadic Alzheimer’s Disease
por: Kocinaj, Altin, et al.
Publicado: (2021)

Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution
por: Parsons, Richard B., et al.
Publicado: (2021)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
por: Togni, Lucrezia, et al.
Publicado: (2021)

The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022)

Nicotinamide N‐methyltransferase is related to MELF pattern invasion in endometrioid carcinoma
por: Tahara, Shinichiro, et al.
Publicado: (2021)

Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer
por: Cao, Li, et al.
Publicado: (2022)

Nicotinamide N-methyltransferase mediates lipofibroblast–myofibroblast transition and apoptosis resistance
por: Rehan, Mohammad, et al.
Publicado: (2023)

Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Obesity in Chinese Han Male College Students
por: Zhou, Qiong, et al.
Publicado: (2017)

Protein arginine methyltransferases: promising targets for cancer therapy
por: Hwang, Jee Won, et al.
Publicado: (2021)

A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
por: Kannt, Aimo, et al.
Publicado: (2018)

Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1
por: You, Zhenyu, et al.
Publicado: (2018)

Nicotinamide-N-methyltransferase controls behavior, neurodegeneration and lifespan by regulating neuronal autophagy
por: Schmeisser, Kathrin, et al.
Publicado: (2018)

Nicotinamide N-methyltransferase induces the proliferation and invasion of squamous cell carcinoma cells
por: Hah, Young-Sool, et al.
Publicado: (2019)

Linkage of nanosecond protein motion with enzymatic methyl transfer by nicotinamide N-methyltransferase
por: JING, Yahui, et al.
Publicado: (2021)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

Targeting nicotinamide N-methyltransferase overcomes resistance to EGFR-TKI in non-small cell lung cancer cells
por: Wang, Jun, et al.
Publicado: (2022)

Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization
por: Wang, Yanzhong, et al.
Publicado: (2019)

CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023)

Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension
por: Fedorowicz, Andrzej, et al.
Publicado: (2016)

Nicotinamide N‐methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes
por: Koppe, Tiago, et al.
Publicado: (2017)

High stromal nicotinamide N‐methyltransferase (NNMT) indicates poor prognosis in colorectal cancer
por: Song, Mengmeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_htfqud0mi5ignqni5lvnn3piid